During COVID-19, S protein–CD147 interaction has been involved in damage to cardiomyocytes [39] as well as in alteration of erythrocyte morphology, eventually resulting in hyperviscosity syndrome [40] and hemolytic anemia [41], and even possibly in neurodegenerative processes [42]. This evidence concerns the gene PROS1 and COVID-19.